Albert David Limited (BOM:524075)

India flag India · Delayed Price · Currency is INR
642.00
-37.15 (-5.47%)
At close: Mar 9, 2026
-27.70%
Market Cap 3.66B
Revenue (ttm) 3.23B
Net Income (ttm) 96.12M
Shares Out 5.71M
EPS (ttm) 16.84
PE Ratio 38.12
Forward PE n/a
Dividend 5.00 (0.74%)
Ex-Dividend Date Jul 25, 2025
Volume 532
Average Volume 332
Open 675.00
Previous Close 679.15
Day's Range 642.00 - 675.00
52-Week Range 642.00 - 959.35
Beta -0.07
RSI 27.51
Earnings Date Feb 11, 2026

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1938
Employees 1,805
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524075
Full Company Profile

Financial Performance

In fiscal year 2025, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.

Financial Statements

News

There is no news available yet.